Potential Medical Benefits of Cannabis sativa and Its Controversies

Malaysian Journal of Medicine and Health Sciences Pub Date : 2023-08-10 DOI:10.47836/mjmhs.19.s9.43

Arisya Hanim Sharol Hisam, Nurfarhana Rasli, Nur Fatihah Abdul Razak, Ain Sofea Nabila Aidy Ajmer, Joe Dailin Daniel, Hesham Ali El Enshasy, Wen Nee Tan, Woei Yenn Tong

{"title":"Potential Medical Benefits of Cannabis sativa and Its Controversies","authors":"Arisya Hanim Sharol Hisam, Nurfarhana Rasli, Nur Fatihah Abdul Razak, Ain Sofea Nabila Aidy Ajmer, Joe Dailin Daniel, Hesham Ali El Enshasy, Wen Nee Tan, Woei Yenn Tong","doi":"10.47836/mjmhs.19.s9.43","DOIUrl":null,"url":null,"abstract":"There are over 40 countries that have legalised the use of Cannabis sativa for medical purposes. The objective of this review is to discuss the benefits of C. sativa usage for medical purposes and the conflicts that may arise from its usage. In terms of neurological disorders, medical C. sativa is effective in reducing the symptoms of neuropathic and peripheral pain, Tic disorder, Parkinson’s Disease, and Alzheimer’s Disease. Besides, C. sativa has been proven to reduce the symptoms of post-traumatic stress disorder, insomnia, anxiety, and schizophrenia. With the legalization of C. sativa for medical purposes, there are conflicts that arise, including public attitudes and social acceptability. In conclusion, medical C. sativa showed significant medical benefits in managing neurological, mental, and other pain-related illnesses. However, C. sativa can also cause conflicts in the legalization process due to adverse effects shown to users after consuming it for a period of time.","PeriodicalId":40029,"journal":{"name":"Malaysian Journal of Medicine and Health Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian Journal of Medicine and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47836/mjmhs.19.s9.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

There are over 40 countries that have legalised the use of Cannabis sativa for medical purposes. The objective of this review is to discuss the benefits of C. sativa usage for medical purposes and the conflicts that may arise from its usage. In terms of neurological disorders, medical C. sativa is effective in reducing the symptoms of neuropathic and peripheral pain, Tic disorder, Parkinson’s Disease, and Alzheimer’s Disease. Besides, C. sativa has been proven to reduce the symptoms of post-traumatic stress disorder, insomnia, anxiety, and schizophrenia. With the legalization of C. sativa for medical purposes, there are conflicts that arise, including public attitudes and social acceptability. In conclusion, medical C. sativa showed significant medical benefits in managing neurological, mental, and other pain-related illnesses. However, C. sativa can also cause conflicts in the legalization process due to adverse effects shown to users after consuming it for a period of time.

查看原文本刊更多论文

大麻的潜在医疗效益及其争议

40多个国家已将医用大麻的使用合法化。本综述的目的是讨论大麻用于医疗目的的好处以及其使用可能产生的冲突。在神经系统疾病方面，医用大麻可有效减轻神经性和周围性疼痛、抽动障碍、帕金森病和阿尔茨海默病的症状。此外，大麻已被证明可以减轻创伤后应激障碍、失眠、焦虑和精神分裂症的症状。随着医用大麻的合法化，出现了包括公众态度和社会可接受性在内的冲突。总之，医用大麻在治疗神经、精神和其他与疼痛有关的疾病方面显示出显著的医疗效益。但是，大麻在吸食一段时间后会出现副作用，因此在合法化过程中也会引发矛盾。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malaysian Journal of Medicine and Health Sciences Medicine-Medicine (all)

CiteScore

0.50

自引率

0.00%

发文量

期刊介绍： The Malaysian Journal of Medicine and Health Sciences (MJMHS) is published by the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. The main aim of the MJMHS is to be a premier journal on all aspects of medicine and health sciences in Malaysia and internationally. The focus of the MJMHS will be on results of original scientific research and development, emerging issues and policy analyses pertaining to medical, biomedical and clinical sciences.